Life Sciences Review

About Us

Conference

Partner With Us

HEOR

An Innovative Approach to HEOR

Advancing Evidence-based, Cost-responsible, and Equitable Healthcare

Ivo Abraham

Chief Scientist

Matrix45

Featured Issue

HEOR: The Role of Data in Delivering Best Patient-Care

Stewart Fossceco, Vice President, Quality Analytics, Invitae

Accelerating Drug Development Of Novel Targeted Therapies Through Histology-Agnostic Oncology Clinical Trials

Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker Zai Lab

Challenges and Opportunities for AI in Drug Discovery

Yong Yue, Senior Director, Computational Biology and Data Sciences Ferring Pharmaceuticals.

Growing Demand For More Specialized Services Specialized Services: A New Paradigm In Therapeutics

Brian Fry, Director, Global Cell Therapy Charles River Laboratories

Mastering the new paradigm in payer value

Stephen Hull, Founder and President

Offering Superior Commercialization Support

Tim Disher, Senior Director, Biostatistics, Value & Evidence

Statistical and Econometric Analysis with ML/AI to support Innovation in Healthcare

Fabian D'Souza, President and Founder

News

Clinical Trial Management Moves Toward A More Connected Model

Biomarker Claims Face Evidence Test

Choosing an ADC and AOC CDMO Partner for Complex Bioconjugates

Biomarker Results Leave Decisions Open

The Value of New Antibiotics in the Fight Against AMR

Piero Rijli, Corporate Director, Regulatory Activities and Market Access

MENARINI Group

Artificial Intelligence and the Healthcare Industry

Kelly H. Zou, PhD, PStat®, FASA, Head of Global Medical Analytics and Real World Evidence, Viatris

Challenges and opportunities in gene therapy clinical development

Haichen Yang, MD, MA, MBA, Vice President, Clinical Research

Amicus Therapeutics Inc.

Accelerating Early-Stage Drug Development

Safwan Kezbor, M.D., Global Medical Lead (Senior Medical Director)

Shionogi Inc

Specials